Skip to main content
SpringerLink
Log in

Autoimmune Lebererkrankungen

  • Chapter
Klinische Hepatologie

  • 108 Accesses

Zusammenfassung

Mit der zunehmenden Entschlüsselung immunologischer Vorgänge hat auch das Interesse an immunologisch bedingten und insbesondere an Autoimmunerkrankungen der Leber zugenommen. Diese relativ seltenen, pathogenetisch und klinisch interessanten Krankheiten vermitteln einen Eindruck der Folgen einer ungebremsten immunologischen Entzündungsreaktion für das hepatobiliäre System. Abgesehen von den wenigen Ausnahmen eines akuten Leberversagens enden alle Autoimmunerkrankungen der Leber unbehandelt in der Leberzirrhose. Je nachdem, ob der Entzündungsprozess primär das Leberparenchym oder das biliäre System betrifft, können

  • hepatitische Erkrankungen (Autoimmunhepatitis) von

  • cholestatischen Erkrankungen (primär biliäre Zirrhose, primär sklerosierende Cholangitis, autoimmune Cholangitis, biliäre Duktopenie [vanishing bile duct syndrome]) abgegrenzt werden. Eine weitere Gruppe mit überlappenden Eigenschaften wird als

  • Überlappungssyndrom bezeichnet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Al-Khalidi JA, Czaja AJ (2001) Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis. Mayo Clin Proc 76: 1237–1252

    Article  PubMed  CAS  Google Scholar 

  • Alvarez F, Berg PA, Bianchi FB et al. (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929–938

    Article  PubMed  CAS  Google Scholar 

  • Ben-Ari Z, Czaja AJ (2001) Autoimmune hepatitis and its variant syndromes. Gut 49: 589–594

    Article  PubMed  CAS  Google Scholar 

  • Beuers U, Wiedmann KH, Kleber G et al. (1997) Therapie der autoimmunen Hepatitis, primär biliären Zirrhose und primär sklerosierenden Cholangitis. Konsensus der Deutschen Gesellschaft für Verdauungs-und Stoffwechselkrankheiten. Z Gastroenterol 35: 1041–1049

    PubMed  CAS  Google Scholar 

  • Bogdanos DP, Choudhuri K, Vergani D (2001) Molecular mimicry and autoimmune liver disease: vituous intentions, malign consequences. Liver 21: 225–322

    Article  PubMed  CAS  Google Scholar 

  • Clemente MG, Meloni A, Obermayer-Straub P et al. (1998) Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology 114: 324–328

    Article  PubMed  CAS  Google Scholar 

  • Czaja AJ (1996) Diagnosis and therapy of autoimmune liver disease. Med Clin North Am 80: 973–994

    PubMed  CAS  Google Scholar 

  • Czaja AJ (2001) Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol 96: 1224–1231

    Article  PubMed  CAS  Google Scholar 

  • Czaja AJ, Manns MP (1995) The validity and importance of subtypes of autoimmune hepatitis: a point of view. Am J Gastroenterol 90: 1206–1211

    PubMed  CAS  Google Scholar 

  • Czaja AJ, Carpenter HA (1996) Validation of a scoring system for the diagnosis of autoimmune hepatitis. Dig Dis Sci 41: 305–314

    Article  PubMed  CAS  Google Scholar 

  • Czaja AJ, Cassani F, Cataleta M et al. (1996) Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24: 1068–1073

    Article  PubMed  CAS  Google Scholar 

  • Czaja AJ, Kruger M, Sanrach PJ et al. (1997) Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol 92: 2197–2200

    PubMed  CAS  Google Scholar 

  • Dienes HP (2000) Autoimmune Hepatitis. In: Denk H, Dienes HP, Düllmann J et al. (Hrsg) Pathologie der Leber und Gallenwege. Springer, Berlin Heidelnerg New York, S 379–389

    Google Scholar 

  • Dienes HP, Popper H, Manns M et al. (1989) Histologic features in autoimmune hepatitis. Z Gastroenterol 27: 325–330

    PubMed  CAS  Google Scholar 

  • Doherty DG, Donaldson PT, Underhill JA et al. (1994) Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 19: 609–615

    Article  PubMed  CAS  Google Scholar 

  • Gerotto M, Pontisso P, Giostra F et al. (1994) Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies. J Hepatol 21: 273–276

    Article  PubMed  CAS  Google Scholar 

  • Gish RG, Mason A (2001) Autoimmune liver disease: current standards, future directions. Clin Liver Dis 5: 287–314

    Article  PubMed  CAS  Google Scholar 

  • Johnson PJ, McFarlane IG (1993) Meeting report of the International Autoimmune Hepatitis Group. Hepatology 18: 998–1005

    Article  PubMed  CAS  Google Scholar 

  • Johnson PJ, McFarlane IG, Williams R (1995) Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 333: 958–963

    Article  PubMed  CAS  Google Scholar 

  • Kanzler S, Weidemann C, Gerken G et al. (1999) Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol 31: 635–640

    Article  PubMed  CAS  Google Scholar 

  • Kernebeck T, Lohse AW, Grotzinger J (2001) A Biolnformatical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen/liver pancreas. Hepatology 34: 230–233

    Article  PubMed  CAS  Google Scholar 

  • Leuschner U (2001) Autoimmunkrankheiten der Leber und Overlapsyndrome. Uni-Med Verlag, Bremen

    Google Scholar 

  • Lohr H, Manns MP, Kyriatsoulis A et al. (1991) Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin Exp Immunol 84: 297–302

    Article  PubMed  CAS  Google Scholar 

  • Manns MP, Griffin KJ, Sullivan KF et al. (1991) LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 mono oxygenase. J Clin Invest 88: 1370–1378

    Article  PubMed  CAS  Google Scholar 

  • Manns MP, Strassburg CP (2001) Autoimmune hepatitis: clinical challenges. Gastroenterology 120: 1502–1517

    Article  PubMed  CAS  Google Scholar 

  • McFarlane IG (1999) Pathogenesis of autoimmune hepatitis. Biomed Pharmacother 53: 255–263

    Article  PubMed  CAS  Google Scholar 

  • Michitaka K, Durazzo M, Tillmann HL et al. (1994) Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology 106: 1603–1610

    PubMed  CAS  Google Scholar 

  • Muratori L, Parola M, Ripalti A et al. (2000) Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 46: 553–561

    Article  PubMed  CAS  Google Scholar 

  • Neuberger J, Portmann B, Calne R et al. (1984) Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation 37: 363–365

    Article  PubMed  CAS  Google Scholar 

  • Pratt DS, Flavin DP, Kaplan MM (1996) The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology 110: 271–274

    Article  PubMed  CAS  Google Scholar 

  • Pratt DS, Fawaz KA, Rabson A et al. (1997) A novel histological lesion in glucocorticoid-responsive chronic hepatitis. Gastroeneterology 113: 664–668

    Article  CAS  Google Scholar 

  • Roberts SK, Therneau TM, Czaja AJ (1996) Prognosis of his tological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 110: 848–857

    Article  PubMed  CAS  Google Scholar 

  • Sanchez-Urdazpal L, Czaja AJ, van Hoek B et al. (1992) Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology 15: 215–221

    Article  PubMed  CAS  Google Scholar 

  • Schalm SW, Summerskill WHJ, Go VLW (1977) Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone. Gastroenterology 72: 910–913

    PubMed  CAS  Google Scholar 

  • Summerskill WHJ (1974) Chronic active liver disease reexamined: prognosis hopeful. Gastroenterology 66: 450–464

    PubMed  CAS  Google Scholar 

  • Summerskill WHJ, Korman MG, Ammon HV et al. (1975) Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 16: 876–883

    Article  PubMed  CAS  Google Scholar 

  • Te HS, Koukoulis G, Granger DR (1997) Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis. Gut 41: 269–271

    Article  PubMed  CAS  Google Scholar 

  • Vogel A, Liermann H, Harms A et al. (2001) Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology 33: 1047–1052

    Article  PubMed  CAS  Google Scholar 

  • Volkmann M, Martin L, Bäurle A et al. (2001) Suluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis. Hepatology 33: 591–596

    Article  PubMed  CAS  Google Scholar 

  • Wesierska-Gadek J, Grimm R, Hitchman E et al. (1998) Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology 114: 329–335

    Article  PubMed  CAS  Google Scholar 

  • Wies I, Brunner S, Henninger J et al. (2000) Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355: 1510–1515

    Article  PubMed  CAS  Google Scholar 

  • Yamamoto AM, Cresteil D, Homberg JC et al. (1993) Characterization of the anti-liver-kidney microsomoe antibody (anti-LKM1) from hepatitis C virus-positive and-negative sera. Gastroenterology 104: 1762–1767

    PubMed  CAS  Google Scholar 

  • Zauli D, Ghetti S, Grassi A et al. (1997) Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 25: 1105–1107

    Article  PubMed  CAS  Google Scholar 

  • Angulo P, Batts KP, Therneau TM et al. (1999) Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology 29: 644–647

    Article  PubMed  CAS  Google Scholar 

  • Angulo P, Lindor KD (1999) Primary biliary cirrhosis and primary sclerosing cholangitis. Clin Liver Dis 3: 529–570

    Article  PubMed  CAS  Google Scholar 

  • Angulo P, Jorgensen RA, Keach JC et al. (2000) Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology 31: 318–323

    Article  PubMed  CAS  Google Scholar 

  • Bach N, Thung SN, Schaffner F (1998) The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis. Arch Pathol Lab Med 122: 342–345

    PubMed  CAS  Google Scholar 

  • Christensen E, Neuberger J, Crowe J et al. (1985) Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: final results of an international trial. Gastroenterology 89: 1084–1091

    PubMed  CAS  Google Scholar 

  • Combes B, Markin RS, Wheeler DE et al. (1999) The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis. Hepatology 30: 602–605

    Article  PubMed  CAS  Google Scholar 

  • Corpechot C, Carrat F, Bonnand AM et al. (2000) The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology 32: 1196–1199

    Article  PubMed  CAS  Google Scholar 

  • Davern TJ, Lake JR (1998) Recurrent disease after liver transplantation. Semin Gastrointest Dis 9: 86–109

    PubMed  CAS  Google Scholar 

  • Dickson E, Grambsch PM, Fleming TR et al. (1989) Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10: 1–7

    Article  PubMed  CAS  Google Scholar 

  • Galperin C, Gershwin ME (1996) Immunopathology of primary biliary cirrhosis. Bailliere’s Clin Gastroenterol 10: 461–481

    Article  CAS  Google Scholar 

  • Goulis J, Leandro G, Burroughs AK (1999) Randomised controlled trials of ursodeoxycholic acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 354: 1053–1060

    Article  PubMed  CAS  Google Scholar 

  • Heathcote EJ (1999) Evidence-based therapy of primary biliary cirrhosis. Eur J Gastroenterol Hepatol 11: 607–615

    Article  PubMed  CAS  Google Scholar 

  • Heathcote EJ (2000) Management of primary biliary cirrhosis. Hepatology 31: 1005–1013

    Article  PubMed  CAS  Google Scholar 

  • Hendrickse M, Rigney E, Giaffer MH et al. (1999) Low-dose methotrexate in primary biliary cirrhosis: long-term results of a placebo controlled trial. Gastroenterology 117: 400–407

    Article  PubMed  CAS  Google Scholar 

  • Hodgson SF, Dickson ER, Wahner HW et al. (1985) Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 103: 855–860

    PubMed  CAS  Google Scholar 

  • Invernizzi P, Podda M, Battezzati PM et al. (2001) Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 34: 366–372

    Article  PubMed  CAS  Google Scholar 

  • James OFW, Bhopal R, Howel D et al. (1999) Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 30: 390–394

    Article  PubMed  CAS  Google Scholar 

  • Jones DEJ, Metcalf JV, Collier JD et al. (1997) Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology 26: 1138–1142

    Article  PubMed  CAS  Google Scholar 

  • Kaplan MM (1996) Primary biliary cirrhosis. N Engl J Med 335: 1570–1580

    Article  PubMed  CAS  Google Scholar 

  • Kim WR, Wiesner RH, Therneau TM et al. (1998) Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology 28: 33–38

    Article  PubMed  CAS  Google Scholar 

  • Kim WR, Lindor KD, Locke III GR et al. (2000) Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 119: 1631–1636

    Article  PubMed  CAS  Google Scholar 

  • Kingham JG, Parker DR (1998) The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 42: 120–122

    Article  PubMed  CAS  Google Scholar 

  • Krzeski P, Zych W, Kraszewska E et al. (1999) Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis? Hepatology 30: 865–869

    Article  PubMed  CAS  Google Scholar 

  • Leuschner U, Güldütüna S, Imhof M et al. (1994) Effect of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis. J Hepatol 21: 624–633

    Article  PubMed  CAS  Google Scholar 

  • Leuschner M, Güldütüna S, You T et al. (1996) Ursodeoxycholie acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol 25: 49–57

    Article  PubMed  CAS  Google Scholar 

  • Leuschner M, Maier KP, Schlichting J et al. (1999) Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhois: results of a prospective double blind trial. Gastroenterology 117: 918–925

    Article  PubMed  CAS  Google Scholar 

  • Leuschner M, Dietrich CF, You T et al. (2000) Characterization of patients with primary biliary cirrhosis responding to long-term ursodeoxycholic acid therapy. Gut 46: 121–126

    Article  PubMed  CAS  Google Scholar 

  • Lindor KD, Dickson ER, Jorgensen RA et al. (1995) The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study. Hepatology 22: 1158–1162

    PubMed  CAS  Google Scholar 

  • Lindor KD, Hoofnagle J, Maddrey WC et al. (1996) Primary biliary cirrhosis clinical research single-topic conference. Hepatology 23: 639–644

    Article  PubMed  CAS  Google Scholar 

  • Lindor KD, Therneau TM, Jorgensen RA et al. (1996) Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 110: 1515–1518

    Article  PubMed  CAS  Google Scholar 

  • Lombard M, Portmann B, Neuberger J (1993) Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology 104: 519–526

    PubMed  CAS  Google Scholar 

  • Ludwig J, Dickson ER, McDonald GS (1978) Staging of non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379: 103–112

    Article  PubMed  CAS  Google Scholar 

  • Mason AL, Xu L, Guo L et al. (1998) Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 351: 1620–1624

    Article  PubMed  CAS  Google Scholar 

  • Metcalf JV, Mitchison HC, Palmer JM et al. (1996) Natural history of early primary biliary cirrhosis. Lancet 348: 1399–1402

    Article  PubMed  CAS  Google Scholar 

  • Mitchison HC, Bassendine MF, Hendrick A et al. (1986) Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology 6: 1279–1284

    Article  PubMed  CAS  Google Scholar 

  • Mitchison HC, Palmer JM, Bassendine MF et al. (1992) A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol 15: 336–344

    Article  PubMed  CAS  Google Scholar 

  • Neuberger J, Thomson R (1999) PBC and AMA — what is the connection? Hepatology 29: 271–276

    Article  PubMed  CAS  Google Scholar 

  • Poupon RE, Poupon R, Balkau B et al. (1994) Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 330: 1342–1347

    Article  PubMed  CAS  Google Scholar 

  • Poupon RE, Lindor KD, Cauch-Dudek K et al. (1997) Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113: 884–890

    Article  PubMed  CAS  Google Scholar 

  • Poupon RE, Bonnand AM, Chretien Y et al. (1999) Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Hepatology 29: 1668–1671

    Article  PubMed  CAS  Google Scholar 

  • Scheuer PJ (1967) Primary biliary cirrhosis. Proc R Soc Med 60: 1257–1260

    PubMed  CAS  Google Scholar 

  • Shapiro JM, Smith H, Schaffner F (1979) Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 20: 137–140

    Article  PubMed  CAS  Google Scholar 

  • Strassburg CP, Jaeckel E, Manns MP (1999) Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 11: 595–601

    Article  PubMed  CAS  Google Scholar 

  • Tanaka A, Borchers AT, Ishibashi H et al. (2001) Genetic and familial considerations of primary biliary cirrhosis. Am J Gastroenterol 96: 8–15

    Article  PubMed  CAS  Google Scholar 

  • Wolfbagen FHJ, van Hoogstraten HJF, van Buuren HR et al. (1998) Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study. J Hepatol 29: 736–742

    Article  Google Scholar 

  • Xu L, Guo L, Joplin R et al. (1997) Viral induction of primary biliary cirrhosis. J Hepatol 2: 61

    Google Scholar 

  • Xu L, Guo L, Keogh A et al. (2000) Isolation and characterization of a novel virus associated with primary biliary cirrhosis. Hepatology 32: 297 A

    Article  Google Scholar 

  • Yamazaki A, Suzuki K, Nakamura A et al. (1999) Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology 30: 71–78

    Article  PubMed  CAS  Google Scholar 

  • Ben-Ari Z, Dhillon AP, Sherlock S (1993) Autoimmune cholangiopathy: part of the spectrum of chronic active hepatitis. Hepatology 18: 10–15

    Article  PubMed  CAS  Google Scholar 

  • Brunner G, Klinge O (1987) Ein der chronisch-destruierenden nichteitrigen Cholangitis ähnliches Krankheitsbild mit antinukleären Antikörpern (Immuncholangitis). Dtsch Med Wochenscher 112: 1454–1458

    Article  CAS  Google Scholar 

  • Carrougher JG, Shaffer RT, Canales LI et al. (1991) A 33-year old woman with an autoimmune syndrome. Semin Liver Dis 11: 256–262

    Article  PubMed  CAS  Google Scholar 

  • Colombato LA, Alvarez F, Cote J et al. (1994) Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 107: 1839–1843

    PubMed  CAS  Google Scholar 

  • Czaja AJ, Carpenter HA, Santrach PJ et al. (2000) Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 31: 1231–1238

    Article  PubMed  CAS  Google Scholar 

  • Goodman ZD, McNally PR, Davis DR et al. (1995) Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic considerations in 200 cases. Dig Dis Sci 40: 1232–1242

    Article  PubMed  CAS  Google Scholar 

  • Heathcote J (1997) Autoimmune cholangitis. Gut 40: 440–442

    PubMed  CAS  Google Scholar 

  • Invernizzi P, Crosignani A, Battezzati PM et al. (1997) Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and-negative primary biliary cirrhosis. Hepatology 25: 1090–1095

    Article  PubMed  CAS  Google Scholar 

  • Kinoshita H, Omagari K, Whittingham S et al. (1999) Autoimmune cholangitis and primary biliary cirrhosis — an autoimmune enigma. Liver 19: 122–128

    Article  PubMed  CAS  Google Scholar 

  • Kitami N, Komada T, Ishii H (1995) Immunological study of anti-M2 in mitochondrial antibody negative primary biliary cirrhosis. Intern Med 34: 496–501

    Article  PubMed  CAS  Google Scholar 

  • Lacerda MA, Ludwig J, Dickson ER et al. (1995) Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 90: 247–249

    PubMed  CAS  Google Scholar 

  • Mohr L, Heintges T, Hensel F et al. (1998) Treatment of autoimmune cholangitis. Dis Dis Sci 43: 2160–2163

    Article  CAS  Google Scholar 

  • Michieletti P, Wanless IR, Katz et al. (1994) Antimitochondrial negative primary biliary cirrhosis: a distinct clinical syndrome of autoimmune cholangitis. Gut 35: 260–265

    Article  PubMed  CAS  Google Scholar 

  • Nakanuma Y, Harada K, Kaji K et al. (1997) Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies. Liver 17: 281–287

    PubMed  CAS  Google Scholar 

  • Sherlock S (1998) Autoimmune cholangitis. A unique entity? Mayo Clin Proc 73: 184–190

    Article  PubMed  CAS  Google Scholar 

  • Taylor SL, Dean PJ, Rieley CA (1994) Primary autoimmune cholangitis: an alternative to antimitochondrial antibodynegative primary biliary cirrhosis. Am J Surg Pathol 18: 91–99

    Article  PubMed  CAS  Google Scholar 

  • Angulo P, Lindor KD (1999) Primary sclerosing cholangitis. Hepatology 30: 325–332

    Article  PubMed  CAS  Google Scholar 

  • Baron TH, Koehler RE, Rodgers WH et al. (1995) Mast cell cholangiopathy: another cause of sclerosing cholangitis. Gastroenterology 109: 1677–1681

    Article  PubMed  CAS  Google Scholar 

  • Bass NM, Chapman RW, O’Reilly A et al. (1983) Primary sclerosing cholangitis associated with angioimmunoblastic lymphadenopathy. Gastroenterology 85: 420–424

    Google Scholar 

  • Dienes HP, Lohse AW, Gerken G et al. (1997) Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 431: 119–124

    Article  PubMed  CAS  Google Scholar 

  • Lindor KD (1997) Ursodiol for primary sclerosing cholangitis. N Engl J Med 336: 691–695

    Article  PubMed  CAS  Google Scholar 

  • Ludwig J (1991) Small-duct primary sclerosing cholangitis. Semin Liver Dis 11: 11–17

    Article  PubMed  CAS  Google Scholar 

  • Ludwig J, Barham SS, LaRusso NF et al. (1981) Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1: 632–640

    Article  PubMed  CAS  Google Scholar 

  • Mitchell SA, Bansi DS, Hunt N et al. (2001) A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 121: 900–907

    Article  PubMed  CAS  Google Scholar 

  • Ponsioen CIJ, Tytgat GNJ (1998) Primary sclrosing cholangitis: a clinical review. Am J Gastroenterol 93: 515–523

    Article  PubMed  CAS  Google Scholar 

  • Ponsioen CIJ, Vrouenraets SME, van Milligen de Wit AWM et al. (1999) Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 31: 305–309

    Article  PubMed  CAS  Google Scholar 

  • Ramos FJ, Perez-Arellano JI, Lopez-Borrasca A (1987) Primary sclerosing cholangitis in histiocytosis X. Am J Med 82: 191

    Article  PubMed  CAS  Google Scholar 

  • Rösch T, Dancygier H (1988) Primär sklerosierende Cholangitis. Leber Magen Darm 18: 184–196

    PubMed  Google Scholar 

  • Stiehl A, Rudolph G, Sauer P et al. (1997) Efficacy of ursodeoxycholic acid treatment and endoscopic dilatation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol 26: 560–566

    Article  PubMed  CAS  Google Scholar 

  • Wiesner RH, Grambsch PM, Dickson ER et al. (1989) Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 10: 430–436

    Article  PubMed  CAS  Google Scholar 

  • Desmet VJ (1997) Vanishing bile duct syndrome in drug-induced liver disease. J Hepatol 26 [suppl 1]: 31–35

    Article  PubMed  CAS  Google Scholar 

  • Garda-Jimenez ME, Quiroga JA, Gutierrez ML et al. (2001) Association of HLA-DR genes with mild idiopathic adulthood ductopenia. Am J Gastroenterol 96: 1178–1182

    Google Scholar 

  • Hübscher SG (1999) Pathology of vanishing bile duct syndromes. In: Neuberger J (ed) Primary biliary cirrhosis. West End Studios Ltd, UK, pp 41–52

    Google Scholar 

  • Ludwig J (1998) Idiopathic adulthood ductopenia: an update. Mayo Clin Proc 73: 285–291

    Article  PubMed  CAS  Google Scholar 

  • Ludwig J, Wiesner RH, LaRusso NF (1988) Idiopathic adulthood ductopenia: a cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 7: 193–199

    Article  PubMed  CAS  Google Scholar 

  • Moreno A, Carreno V, Cano A (1997) Idiopathic biliary ductopenia in adults without symptoms of liver disease. N Engl J Med 336: 835–838

    Article  PubMed  CAS  Google Scholar 

  • Müller C, Ulrich W, Penner E (1995) Manifestation late in life of idiopathic adulthood ductopenia. Liver 15: 213–218

    PubMed  Google Scholar 

  • Woolf GM, Vierling JM (1993) Disappearing intrahepatic bile ducts: the syndromes and their mechanisms. Semin Liver Dis 13: 261–275

    Article  PubMed  CAS  Google Scholar 

  • Zafrani ES, Metreau JM, Douvin C et al. (1990) Idiopathic biliary ductopenia in adults: a report of five cases. Gastroenterology 99: 1823–1828

    PubMed  CAS  Google Scholar 

  • Ben Ari Z, Dhillon AP, Sherlock S (1993) Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 18: 10–15

    Article  Google Scholar 

  • Ben Ari Z, Czaja AT (2001) Autoimmune hepatitis and its variant syndromes. Gut 49: 589–594

    Article  Google Scholar 

  • Boberg KM, Fausa O, Haaland T et al. (1996) Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 23: 1369–1376

    Article  PubMed  CAS  Google Scholar 

  • Chazouillieres O (2000) Diagnosis of primary sclerosing cholangitis — autoimmune hepatitis overlap syndrome; to score or not to score? J Hepatol 33; 661–663

    Article  Google Scholar 

  • Chazouillieres O, Wendum D, Serfaty L et al. (1998) Primary biliary cirrhosis — autoimmune hepatitis overlap syndrome; clinical features and response to therapy. Hepatology 28: 296–301

    Article  Google Scholar 

  • Czaja AJ (1996) The variant forms of autoimmune hepatitis. Ann Intern Med 125; 588–598

    PubMed  CAS  Google Scholar 

  • Czaja AJ (1998) Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 28: 360–365

    Article  PubMed  CAS  Google Scholar 

  • Gohlke F, Lohse AW, Dienes HP et al. (1996) Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 24; 699–705

    Article  PubMed  CAS  Google Scholar 

  • Kanzler S, Bozkurt S, Herkel J et al. (2001) Nachweis von SLAI LP-Autoantikörpern bei Patienten mit primär biliärer Zirrhose als Marker für eine sekundäre autoimmune Hepatitis (Overlapsyndrom). Dtsch Med Wochenschr 126: 450–456

    Article  PubMed  CAS  Google Scholar 

  • Kaserer K, Exner M, Mosberger I et al. (1998) Characterization of the inflammatory infiltrate in autoimmune cholangitis. A morphological and immunohistochemical study. Virchows Arch 432: 217–222

    Article  PubMed  CAS  Google Scholar 

  • Kaya M, Angulo P, Lindor KD (2000) Overlap of autoimmune hepatitis and primary sclerosing cholangitis; an evaluation of a modified scoring system. J Hepatol 33: 537–542

    Article  PubMed  CAS  Google Scholar 

  • Kim WR, Ludwig J, Lindor KD (2000) Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol 95: 1130–1138

    Article  PubMed  CAS  Google Scholar 

  • Lohse AW, Meyer zum Büschenfelde KH, Franz B et al. (1999) Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis; evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 29: 1978–1984

    Article  Google Scholar 

  • Michieletti P, Wanless IR, Katz A et al. (1994) Antimitochondrial antibody negative primary biliary cirrhosis; a distinct syndrome of autoimmune cholangitis. Gut 35: 260–265

    Article  PubMed  CAS  Google Scholar 

  • Rubel LR, Seeff LB, Patel V (1984) Primary biliary cirrhosisprimary sclerosing cholangitis overlap syndrome. Arch Pathol Lab Med 108: 360–361

    PubMed  CAS  Google Scholar 

  • Van Buuren HR, van Hoogstraten HJF, Terkivatan T et al. (2000) High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 33: 543–548

    Article  PubMed  Google Scholar 

  • Woodward J, Neuberger J (2001) Autoimmune overlap syndromes. Hepatology 33: 994–1002

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Dancygier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dancygier, H. (2003). Autoimmune Lebererkrankungen. In: Klinische Hepatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55902-0_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55902-0_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-67559-4

  • Online ISBN: 978-3-642-55902-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation